Vancomycin MIC Does Not Predict 90-Day Mortality, Readmission, or Recurrence in a Prospective Cohort of Adults with Staphylococcus aureus Bacteremia

Staphylococcus aureus bacteremia (SAB) is a tremendous health burden. Previous studies examining the association of vancomycin MIC and outcomes in patients with SAB have been inconclusive. This study evaluated the association between vancomycin MICs and 30- or 90-day mortality in individuals with SA...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Antimicrob Agents Chemother
Main Authors: Baxi, Sanjiv M., Clemenzi-Allen, Angelo, Gahbauer, Alice, Deck, Daniel, Imp, Brandon, Vittinghoff, Eric, Chambers, Henry F., Doernberg, Sarah
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2016
Assuntos:
Susceptibility
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4997864/
https://ncbi.nlm.nih.gov/pubmed/27324762
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00658-16
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados